Hyperechogenic fetal bowel: Current evidence‐based prenatal diagnosis and management
Journal of Clinical Ultrasound · 2023-09 · 51 (7) · 1172-1178
DOI: 10.1002/jcu.23528 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Journal of Clinical Ultrasound, online erschienen am 08.08.2023. Verfasst von Flaminia Vena und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Maternal and Child Health and Urological Sciences, Sapienza University of Rome, Rome, Italy. Hauptthemen laut MEDLINE: Pregnancy Outcome, Echogenic Bowel. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 44 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Echogenic fetal bowel (EB) is a prenatal ultrasound finding (0.2%–1.4% of all pregnancies) defined as bowel of similar or greater echogenicity than surrounding bone. In fact, the ultrasound assessment is strongly subjective with inter‐observer variability. The pathophysiology depends on the underlying condition, apparently related with meconium stasis and hypercellularity. It is often an isolated finding, with possible association with other structural anomalies. About the origin, it was observed in fetuses with cystic fibrosis, congenital infections, thalassemia, intraamniotic bleeding, fetal growth restriction. Fetuses with EB are at increased risk of adverse perinatal outcome, such as intrauterine growth restriction, placental dysfunction and perinatal death, highlighting the need for a thorough antenatal management and post‐natal follow‐up. It seems to be associated with a plenty of conditions, such as a poor fetal outcome, fetal growth restriction and placental dysfunction. Therefore management requires a multidisciplinary approach with different specialties' involvement and the prognosis is influenced by the underlying pathophysiology. In this complex scenario, the present review aims to define the clinical pathway which should be offered to pregnant women in case of finding of fetal EB ultrasound marker, to rule out any suspected pathological cause.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Maternal and Child Health and Urological Sciences, Sapienza University of Rome, Rome, Italy.
- Department of Experimental Medicine, Sapienza University of Rome, Rome, Italy.
- Sapienza University of Rome, Rome, Italy.
- Obstetrics and Gynecology Department, USL Roma 2, Sant'Eugenio Hospital, Rome, Italy.
ORCID-Profile: Flaminia Vena, Adele Vasta, Elena D'Alberti, Daniele Di Mascio, Valentina D'Ambrosio
Zitieren
APA
Vena, F., Mazza, A., Bartolone, M., Vasta, A., D'Alberti, E., Di Mascio, D., D'Ambrosio, V., Volpe, G., Signore, F., Pizzuti, A., & Giancotti, A. (2023). Hyperechogenic fetal bowel: Current evidence‐based prenatal diagnosis and management. Journal of Clinical Ultrasound, 51(7), 1172-1178. https://doi.org/10.1002/jcu.23528
Vancouver
Vena F, Mazza A, Bartolone M, Vasta A, D'Alberti E, Di Mascio D, et al. Hyperechogenic fetal bowel: Current evidence‐based prenatal diagnosis and management. Journal of Clinical Ultrasound. 2023;51(7):1172-1178. doi:10.1002/jcu.23528
BibTeX
@article{Vena2023,
author = {Vena, Flaminia and Mazza, Alessandra and Bartolone, Martina and Vasta, Adele and D'Alberti, Elena and Di Mascio, Daniele and D'Ambrosio, Valentina and Volpe, Gregorio and Signore, Fabrizio and Pizzuti, Antonio and Giancotti, Antonella},
title = {Hyperechogenic fetal bowel: Current evidence‐based prenatal diagnosis and management},
journal = {Journal of Clinical Ultrasound},
year = {2023},
volume = {51},
number = {7},
pages = {1172--1178},
doi = {10.1002/jcu.23528}
}
EUVIMED